Source: Markets Insider

Aristea: Aristea Therapeutics Announces Key Leadership Appointments to Advance Its Clinical Pipeline

SAN DIEGO, Jan. 13, 2022 /PRNewswire/ -- Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing no...

Read full article »
Aristea's Competitors | Aristea's News | Aristea's Financials
Stay up-to-date with the latest news on Aristea
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
James Mackay's photo - President & CEO of Aristea

President & CEO

James Mackay

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on Aristea